Clinical Endoscopy

The Korean Society of Gastrointestinal Endoscopy (대한소화기내시경학회)
권호 표지
DOI QR코드

DOI QR Code

Echoendoscopic evaluation of the vascular pattern of solid pancreatic lesions as a predictor of neuroendocrine neoplasms: a retrospective study in Mexico

  • Received : 2025.09.04
  • Accepted : 2025.11.16
  • Published : 2026.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background/Aims: Endoscopic ultrasonography (EUS) is essential for evaluating solid pancreatic lesions (SPL). Pancreatic neuroendocrine neoplasms (pNEN) account for 2% of SPL and typically show hypervascularity. This study aimed to assess whether a specific vascular pattern could predict pNEN. Methods: Patients who underwent EUS for a SPL and were histologically diagnosed with pNEN were included. Tissues were obtained using endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) and/or surgical resection. Power Doppler was used to assess the vascular patterns. Patients with pNEN were compared to those diagnosed with pancreatic ductal adenocarcinoma during the same period. Group comparisons by size and histological grade were performed using the chi-square test. Logistic regression analysis identified the EUS features associated with pNEN. Results: Among 125 patients (43 pNEN), a peripheral vascular rim (PVR) was associated with pNEN (odds ratio [OR], 2.8; 95% confidence interval [CI], 1.7-8.5; p=0.03), with 100% specificity. Hypervascularity (OR, 3.8; 95% CI, 1.1-13.4; p=0.03) and pancreatic atrophy (OR, 0.3; 95% CI, 0.1-0.9; p=0.04) were also associated. Conclusions: PVR demonstrated 100% specificity and 34.9% sensitivity for pNEN diagnosis, serving as a rule-in sign. PVR visualization may aid in differential diagnosis when EUS-FNB is unavailable or inconclusive.

Keywords

References

  1. Sultana Q, Kar J, Verma A, et al. A comprehensive review on neuroendocrine neoplasms: presentation, pathophysiology and management. J Clin Med 2023;12:5138.
  2. Pavel M, Öberg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2020;31:844–860. https://doi.org/10.1016/j.annonc.2020.03.304
  3. Stoop TF, Javed AA, Oba A, et al. Pancreatic cancer. Lancet 2025;405:1182–1202. https://doi.org/10.1016/S0140-6736(25)00261-2
  4. Scoazec JY. Angiogenesis in neuroendocrine tumors: therapeutic applications. Neuroendocrinology 2013;97:45–56. https://doi.org/10.1159/000338371
  5. Manta R, Nardi E, Pagano N, et al. Pre-operative diagnosis of pancreatic neuroendocrine tumors with endoscopic ultrasonography and computed tomography in a large series. J Gastrointestin Liver Dis 2016;25:317–321. https://doi.org/10.15403/jgld.2014.1121.253.ned
  6. Khashab MA, Yong E, Lennon AM, et al. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors. Gastrointest Endosc 2011;73:691–696. https://doi.org/10.1016/j.gie.2010.08.030
  7. Ignee A, Jenssen C, Arcidiacono PG, et al. Endoscopic ultrasound elastography of small solid pancreatic lesions: a multicenter study. Endoscopy 2018;50:1071–1079. https://doi.org/10.1055/a-0588-4941
  8. Franchellucci G, Andreozzi M, Carrara S, et al. Contrast enhanced EUS for predicting solid pancreatic neuroendocrine tumor grade and aggressiveness. Diagnostics (Basel) 2023;13:239.
  9. Martinoli C, Pretolesi F, Crespi G, et al. Power Doppler sonography: clinical applications. Eur J Radiol 1998;27 Suppl 2:S133–S140. https://doi.org/10.1016/S0720-048X(98)00054-0
  10. Giovannini M. Endoscopic ultrasound elastography. Pancreatology 2011;11 Suppl 2:34–39. https://doi.org/10.1159/000323496
  11. Satturwar SP, Pantanowitz JL, Manko CD, et al. Ki-67 proliferation index in neuroendocrine tumors: can augmented reality microscopy with image analysis improve scoring? Cancer Cytopathol 2020;128:535–544. https://doi.org/10.1002/cncy.v128.8
  12. Fujii Y, Matsumoto K, Kato H, et al. Diagnostic ability of convex-arrayed endoscopic ultrasonography for major vascular invasion in pancreatic cancer. Clin Endosc 2019;52:479–485. https://doi.org/10.5946/ce.2018.163
  13. Chen K, Zhang W, Zhang Z, et al. Simple vascular architecture classification in predicting pancreatic neuroendocrine tumor grade and prognosis. Dig Dis Sci 2018;63:3147-3152. https://doi.org/10.1007/s10620-018-5240-z
  14. Kitano M, Kudo M, Yamao K, et al. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography. Am J Gastroenterol 2012;107:303–310. https://doi.org/10.1038/ajg.2011.354
  15. Yamashita Y, Kitano M. Role of contrast-enhanced harmonic endoscopic ultrasonography (EUS) and EUS elastography in pancreatic lesions. Clin Endosc 2024;57:164–174. https://doi.org/10.5946/ce.2023.074
  16. Kleemann T, Freund R, Braden B, et al. An international survey on the geographical differences in practice patterns and training of endoscopic ultrasound. J Transl Int Med 2025;13:48–64. https://doi.org/10.1515/jtim-2025-0006
  17. Palazzo M, Napoléon B, Gincul R, et al. Contrast harmonic EUS for the prediction of pancreatic neuroendocrine tumor aggressiveness (with videos). Gastrointest Endosc 2018;87:1481–1488. https://doi.org/10.1016/j.gie.2017.12.033
  18. Paulson EK, McDermott VG, Keogan MT, et al. Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology 1998;206:143–150. https://doi.org/10.1148/radiology.206.1.9423664
  19. Lee DW, Kim MK, Kim HG. Diagnosis of pancreatic neuroendocrine tumors. Clin Endosc 2017;50:537–545. https://doi.org/10.5946/ce.2017.131
  20. Téllez-Ávila FI, Acosta-Villavicencio GY, Chan C, et al. Diagnostic yield of endoscopic ultrasound in patients with hypoglicemia and insulinoma suspected. Endosc Ultrasound 2015;4:52–55. https://doi.org/10.4103/2303-9027.151349
  21. Chiang HC, Huang CJ, Wang YS, et al. Identification of endosonographic features that compromise EUS-FNB diagnostic accuracy in pancreatic masses. Dig Dis Sci 2024;69:4302–4310.
  22. Bergsland E, Ganti AK, Lieu C, et al. NCCN guidelines [Internet]. National Comprehensive Cancer Network; 2025 [cited 2025 May 6]. Available from: https://www.nccn.org/guidelines/guidelines-detail?id=1448
  23. Eusebi LH, Thorburn D, Toumpanakis C, et al. Endoscopic ultrasound-guided fine-needle aspiration vs fine-needle biopsy for the diagnosis of pancreatic neuroendocrine tumors. Endosc Int Open 2019;7:E1393–E1399. https://doi.org/10.1055/a-0967-4684
  24. Iordache S, Angelescu R, Filip MM, et al. Power Doppler endoscopic ultrasound for the assessment of pancreatic neuroendocrine tumors. Endosc Ultrasound 2012;1:150-155. https://doi.org/10.4103/2303-9027.117735